Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| H.J. Harkins Company, Inc. | Grover Beach, California, United States | Makes it, repackages it and relabels it | Problems found, fixed voluntarilyMar 3, 2023 · 5 inspections |
Recalls
- Mar 4, 2019 · Class II · H J Harkins Company Inc dba Pharma Pac
CGMP Deviations:Traces amounts of N-Nitroso N-Methyl 4- amino butyric acid (NMBA) impurity found in Active Pharmaceutical Ingredient (API).
Lots: Pharma Pac NDC: 76519-1033-03, Pharma Pac Lot # LTO00EW, Exp. 11/19, MFG NDC 31722-0702-30, MFG Lot # LOP17087, Exp. 11/2019.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Losartan: every company that makes it
- Form
- tablet
- Strength
- 100 mg
- Approval
- ANDA ANDA203835
- On the market since
- Jan 14, 2016
- Package NDCs
76519-1033-176519-1033-276519-1033-376519-1033-876519-1033-9- Official label
- DailyMed (National Library of Medicine), updated Aug 26, 2019
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?